Work

Phase 2 trial of imatinib mesylate (IM) for treatment of recurrent or refractory pediatric solid tumors: A Children’s Oncology Group study

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.8520

Authors: M. Bond, M. L. Bernstein, A. Pappo, K. R. Schultz, M. Krailo, M. Fouladi, D. A. Hill, M. Heinrich, S. Blaney, P. C. Adamson

Institutions: St. Jude Children's Research Hospital, Washington University in St. Louis, OHSU Knight Cancer Institute

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590227877

Cites:

Cited by: 3

Related to: 10